Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001949864-24-000019
Filing Date
2024-09-13
Accepted
2024-09-13 13:21:52
Documents
34
Period of Report
2024-07-31

Document Format Files

Seq Description Document Type Size
1 maga10q_07312024.htm   iXBRL 10-Q 256146
7 ex31.htm EX-31.1 14274
8 ex32.htm EX-32.1 5240
  Complete submission text file 0001949864-24-000019.txt   1397938

Data Files

Seq Description Document Type Size
2 none-20240731_cal.xml EX-101.CAL 21641
3 none-20240731_def.xml EX-101.DEF 12174
4 none-20240731_pre.xml EX-101.PRE 74998
5 none-20240731.xsd EX-101.SCH 11076
6 none-20240731_lab.xml EX-101.LAB 102399
37 EXTRACTED XBRL INSTANCE DOCUMENT maga10q_07312024_htm.xml XML 107159
Mailing Address 325 W WASHINGTON ST, STE 2877 SAN DIEGO CA 92103
Business Address 325 W WASHINGTON ST, STE 2877 SAN DIEGO CA 92103 16204692043
Mag Magna Corp (Filer) CIK: 0001949864 (see all company filings)

EIN.: 981626237 | State of Incorp.: WY | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-268561 | Film No.: 241297184
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)